Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HCA Healthcare Plans to Build Three Hospitals in Florida in 2022

11/30/2021 | 02:59pm EST


© MT Newswires 2021
All news about HCA HEALTHCARE, INC.
07:32aHCA Healthcare Reports Fourth Quarter 2021 Results and Provides 2022 Guidance
BU
07:32aEarnings Flash (HCA) HCA HEALTHCARE Reports Q4 Revenue $15.06B
MT
01/26HCA Healthcare Announces Plans to Build Five New Hospitals in Texas
BU
01/26HCA Healthcare Appoints Andrea Smith as New Independent Director
BU
01/19HCA Healthcare Announces HCA Healthcare Foundation's $1.35 Million Grant to Educate Tex..
BU
01/10HCA Healthcare, Inc. 4th Quarter 2021 Earnings Conference Call
BU
01/10Citigroup Analyst Starts HCA Healthcare at Buy, Up From Neutral; Price Target is $306
MT
01/07INSIDER SELL : Hca Healthcare
MT
01/05Truist Securities Adjusts HCA Healthcare Price Target to $310 From $290, Maintains Buy ..
MT
01/04HCA Healthcare Acquires MD Now Urgent Care for Undisclosed Sum
MT
More news
Analyst Recommendations on HCA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 59 073 M - -
Net income 2021 6 462 M - -
Net Debt 2021 32 162 M - -
P/E ratio 2021 12,0x
Yield 2021 0,80%
Capitalization 74 645 M 74 645 M -
EV / Sales 2021 1,81x
EV / Sales 2022 1,73x
Nbr of Employees 235 000
Free-Float 77,1%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 240,00 $
Average target price 284,30 $
Spread / Average Target 18,5%
EPS Revisions
Managers and Directors
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Thomas Fearn Frist Chairman
P. Martin Paslick VP-Information Technology & Services
Kathleen M. Whalen Senior VP, Chief Ethics & Compliance Officer
Sector and Competitors